Health Care Company AbbVie Announces Acquisition of Immunogen
November 30, 2023 at 10:10 AM EST
AbbVie (NYSE:ABBV) has announced an acquisition of Immunogen (NASDAQ:IMGN) that is expected to be completed 2024-H1. Under the terms of ...
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.